Cited by 48Parkinson's Disease Mechanisms and TreatmentsDermatology and Skin Diseasesmelanin and skin pigmentation

The DOI matches its Crossref record.

Effect of L-dopa on the seborrhoea of Parkinsonism

BURTON, J.L., CARTLIDGE, MARGARET, SHUSTER, SAM·1973·British Journal of Dermatology

Abstract

By studying the sebum excretion rate in patients with Parkinsonism before and during treatment with L‐dopa we have shown that L‐dopa reduces sebum excretion if seborrhoea is initially present, but has no effect on normal sebum excretion rates. The seborrhoea of Parkinsonism may be due to increased production of melanocyte‐stimulating hormone, and our finding may have therapeutic implications in Parkinsonism and breast cancer.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.1973.tb15453.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • α-melanocyte stimulating hormone (α-MSH) levels were elevated in Parkinson patients, possibly due to inadequate dopaminergic input.

    “Consistent with this notion, α-melanocyte stimulating hormone (α-MSH) levels were elevated in Parkinson patients, possibly due to inadequate dopaminergic input.”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [92]

  • Treatment with L-dopa reduced α-MSH and re-established the synthesis of MSH-inhibiting factor, reducing sebum secretion.

    “Moreover, treatment with L-dopa reduced α-MSH, and re-established the synthesis of MSH-inhibiting factor, reducing sebum secretion [26,92].”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [92]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 18

  1. 10.1016/S0140-6736(70)92476-1 · DOI · Paper page
  2. Buhton J.L., 1970, British Medical Journal, 1, 665, 10.1136/bmj.1.5697.665 · DOI
  3. 10.1016/S0140-6736(71)90082-1 · DOI
  4. Burton J.L., 1973, British Journal of Dermatology, 88, 263, 10.1111/j.1365-2133.1973.tb07545.x · DOI · Paper page
  5. 10.1016/S0140-6736(71)91782-X · DOI
  6. Cotzias G.C., 1967, New England Journal of Medicine, 276, 374, 10.1056/NEJM196702162760703 · DOI
  7. Cunliffe W.J., 1969, British Journal of Dermatology, 81, 697, 10.1111/j.1365-2133.1969.tb16211.x · DOI
  8. 10.1001/archderm.103.5.492 · DOI
  9. J.L. Hayward, H.J.N. Atkins, M.A. Falconer, K.S. Maclean, C.F.W. Salmon, P.H. Sciiurr, and C.H. Shaheen(1970 ) 2nd Tenovus Workshop, Human Breast Cancer, Cardiff, p. 50 .
  10. Kamberi I.A., 1970, Federation Proceedings, 29, 378
  11. 10.1038/227714a0 · DOI
  12. Kamberi I.A., 1971, Endocrinology, 88, 1012, 10.1210/endo-88-4-1012 · DOI
  13. Krant M.J., 1968, Nature, 217, 463, 10.1038/217463b0 · DOI
  14. 10.1016/S0140-6736(72)91249-4 · DOI
  15. 10.1016/S0140-6736(72)90875-6 · DOI
  16. Strauss J.S., 1961, Journal of Investigative Dermatology, 36, 293, 10.1038/jid.1961.48 · DOI
  17. Thody A.J., 1971, Journal of Endocrinology, 51, 6
  18. 10.1038/237346a0 · DOI

Cited by

Sorted by citations

Metadata

Authors
BURTON, J. L., CARTLIDGE, M., & SHUSTER, S.
Affiliations
Newcastle University (GB)
Venue
British Journal of Dermatology
Published
1973-05
Volume
88
Issue
5
Pages
475-479
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2009923372
Cited by
48
References
0
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2020: 4 · 2019: 2 · 2018: 1 · 2015: 2 · 2013: 1 · 2012: 1
FWCI
3.22
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
Keywords
L-DOPA, parkinsonism, seborrhea, sebum excretion rate, melanocyte-stimulating hormone, breast cancer
MeSH terms
Adult, Aged, Depression, Chemical, Dihydroxyphenylalanine, Female, Humans, Male, Middle Aged, Parkinson Disease, Sebaceous Glands, Dermatitis, Seborrheic, Sebum, Secretory Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review